Bellerophon Therapeutics Inc (BLPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Operating Expenses | 22,384 | 20,161 | 26,276 | 17,473 | 27,880 |
| Operating Income | -22,384 | -20,161 | -26,276 | -17,473 | -27,880 |
| Other Income | 136 | 605 | -577 | 2,405 | 25,255 |
| Pre-tax Income | -22,248 | -19,556 | -26,853 | -15,068 | -2,625 |
| Income Tax | -2,417 | -1,800 | -2,125 | -1,801 | -5,439 |
| Net Income Continuous | -19,831 | -17,756 | -24,728 | -13,267 | 2,814 |
| Net Income | $-19,831 | $-17,756 | $-24,728 | $-13,267 | $2,814 |
| EPS Basic Total Ops | -2.08 | -1.87 | -3.17 | -2.95 | 0.73 |
| EPS Basic Continuous Ops | -2.08 | -1.87 | -3.17 | -2.95 | 0.73 |
| EPS Diluted Total Ops | -2.08 | -1.87 | -3.17 | -2.95 | -5.07 |
| EPS Diluted Continuous Ops | -2.08 | -1.87 | -3.17 | -2.95 | 0.65 |
| EPS Diluted Before Non-Recurring Items | -2.08 | -1.87 | -3.06 | -2.95 | -5.10 |
| EBITDA(a) | $-22,319 | $-20,059 | $-26,129 | $-17,125 | $-27,518 |